US Patent Issued to BIOSION on Feb. 24 for "Antibodies binding CTLA4 and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,565, issued on Feb. 24, was assigned to BIOSION INC. (Nanjing, China).

"Antibodies binding CTLA4 and uses thereof" was invented by Mingjiu Chen (Nanjing, China) and Shukai Xia (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated monoclonal antibody that specifically binds human CTLA4, or the antigen-binding portion thereof. A nucleic acid molecule encoding the antibody or the antigen-binding portion thereof, an expression vector, a host cell and a method for expressing the antibody or the antigen-binding portion thereof are also provided. The present disclosure further provides an immunoconjugate, a bispecific molecule, a chime...